PNC Financial Services Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4K Buy
461
+337
+272% +$8.44K ﹤0.01% 4068
2026
Q1
$3.1K Sell
124
-4,615
-97% -$130K ﹤0.01% 4451
2025
Q4
$149K Sell
4,739
-4,389
-48% -$146K ﹤0.01% 2514
2025
Q3
$326K Buy
9,128
+4,408
+93% +$201K ﹤0.01% 1946
2025
Q2
$272K Buy
4,720
+4,150
+728% +$235K ﹤0.01% 1995
2025
Q1
$33.2K Sell
570
-1,455
-72% -$99.3K ﹤0.01% 3306
2024
Q4
$163K Sell
2,025
-1,582
-44% -$135K ﹤0.01% 2359
2024
Q3
$289K Buy
3,607
+2,408
+201% +$171K ﹤0.01% 1932
2024
Q2
$73.2K Buy
1,199
+1,175
+4,896% +$69.9K ﹤0.01% 2825
2024
Q1
$1.19K Buy
+24
New +$1.14K ﹤0.01% 4329
2023
Q4
Sell
-34
Closed -$1.12K 4734
2023
Q3
$1.12K Buy
+34
New +$1.16K ﹤0.01% 4353
2022
Q3
Sell
-26,398
Closed -$863K 4574
2022
Q2
$863K Buy
+26,398
New +$960K ﹤0.01% 1239

Other funds holding PRCT

PNC Financial Services Group's PRCT Position: Q2 2026 in Review

PNC Financial Services Group increased its Procept Biorobotics (PRCT) stake by 272% in Q2 2026, buying an estimated $8.44K and bringing the position to 461 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4068.

PNC Financial Services Group first reported a position in PRCT in Q2 2022 and has held it in 12 quarters since. The position peaked at $863K in Q2 2022. 98 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • PNC Financial Services Group held 461 shares of Procept Biorobotics worth $10.4K as of Q2 2026.
  • PNC Financial Services Group bought 337 Procept Biorobotics shares in Q2 2026, an estimated $8.44K.
  • Procept Biorobotics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4068 holding.
  • PNC Financial Services Group first reported a position in Procept Biorobotics in Q2 2022 and has held it in 12 quarters since.
  • PNC Financial Services Group's Procept Biorobotics position peaked at $863K in Q2 2022.
  • 98 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.